Research peptide encyclopedia
Neutral, in-vitro / preclinical profiles of research peptides, plus a live scientific search across the PubMed literature. For laboratory research only.
Research axes
Explore research peptides by area to find compounds relevant to your field of study.
Metabolic
Peptides studied in research on metabolism, lipid oxidation and appetite regulation.
Growth hormone
Compounds studied on GH secretion, IGF-1 pathways and anabolic signalling.
Tissue repair
Peptides studied on the repair of tissues, tendons, ligaments and wound healing.
Cognition & focus
Compounds studied on cognition, neuroprotection and synaptic plasticity.
Longevity & anti-ageing
Peptides studied on cellular senescence, telomeres and markers of ageing.
Skin & hair
Peptides studied on skin, collagen, hair and cutaneous anti-ageing.
Hormonal balance
Peptides studied on hormonal balance and the reproductive axis.
Immunity
Peptides studied on immune modulation and the body's defences.
Scientific search engine
Live results from PubMed (NCBI). Research literature only — no medical advice.
LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept.
Coskun T, et al. · Cell metabolism · 2022
LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial.
Urva S, et al. · Lancet (London, England) · 2022
Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial.
Jastreboff AM, et al. · The New England journal of medicine · 2023
Efficacy and Safety of GLP-1 Medicines for Type 2 Diabetes and Obesity.
Drucker DJ · Diabetes care · 2024
Incretin triple agonist retatrutide (LY3437943) alleviates obesity-associated cancer progression.
Marathe SJ, et al. · npj metabolic health and disease · 2025
Retatrutide-A Game Changer in Obesity Pharmacotherapy.
Katsi V, et al. · Biomolecules · 2025
What is the pipeline for future medications for obesity?
Melson E, et al. · International journal of obesity (2005) · 2025
Incretin-Based Weight Loss Pharmacotherapy: Can Resistance Exercise Optimize Changes in Body Composition?
Locatelli JC, et al. · Diabetes care · 2024
Emerging pharmacotherapies for obesity: A systematic review.
Kokkorakis M, et al. · Pharmacological reviews · 2025
Gut hormones and appetite regulation.
Hong SH, et al. · Current opinion in endocrinology, diabetes, and obesity · 2024
Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss Among Adults Without Diabetes : A Systematic Review of Randomized Controlled Trials.
Moiz A, et al. · Annals of internal medicine · 2025
Weight management treatment in obesity.
Rubio-Herrera MA, et al. · Medicina clinica · 2025
Retatrutide for the treatment of obesity, obstructive sleep apnea and knee osteoarthritis: Rationale and design of the TRIUMPH registrational clinical trials.
Giblin K, et al. · Diabetes, obesity & metabolism · 2026
The impact of weight loss on fat-free mass, muscle, bone and hematopoiesis health: Implications for emerging pharmacotherapies aiming at fat reduction and lean mass preservation.
Stefanakis K, et al. · Metabolism: clinical and experimental · 2024
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA.
Rosenstock J, et al. · Lancet (London, England) · 2023
Peptide profiles
BPC-157
A pentadecapeptide studied in preclinical tissue-repair research.
Read
TB-500
A synthetic fragment related to Thymosin Beta-4, studied in cell-migration research.
Read
GHK-Cu
A copper tripeptide (Gly-His-Lys) studied in in-vitro dermatological research.
Read
AHK-Cu
A copper tripeptide (Ala-His-Lys) studied in vitro on the hair follicle.
Read
Retatrutide
A multi-receptor research compound studied in a metabolic context.
ReadPeptide directory
A broad index of research peptides — class-level descriptors, each linking to the PubMed literature. Research use only.
| Peptide | Category | Structure | Research application | PubMed |
|---|---|---|---|---|
| BPC-157 | Tissue repair | Pentadecapeptide (15 aa) | Studied in preclinical / in-vitro research on tissue repair. | View |
| TB-500 | Tissue repair | Thymosin β4 fragment | Studied in preclinical / in-vitro research on cell migration. | View |
| GHK-Cu | Skin & hair | Copper tripeptide (Gly-His-Lys) | Studied in preclinical / in-vitro research on the extracellular matrix. | View |
| AHK-Cu | Skin & hair | Copper tripeptide (Ala-His-Lys) | Studied in preclinical / in-vitro research on the hair follicle. | View |
| Retatrutide | Metabolic | Triple-receptor agonist (investigational) | Studied in preclinical / in-vitro research on metabolism. | View |
| Semaglutide | Metabolic | GLP-1 receptor agonist | Studied in preclinical / in-vitro research on metabolism. | View |
| Tirzepatide | Metabolic | Dual GIP/GLP-1 agonist | Studied in preclinical / in-vitro research on metabolism. | View |
| Cagrilintide | Metabolic | Amylin analogue | Studied in preclinical / in-vitro research on metabolism. | View |
| Survodutide | Metabolic | Dual GLP-1/glucagon agonist (investigational) | Studied in preclinical / in-vitro research on metabolism. | View |
| AOD-9604 | Metabolic | hGH fragment (176-191) | Studied in preclinical / in-vitro research on lipid metabolism. | View |
| MOTS-c | Metabolic | Mitochondrial-derived peptide | Studied in preclinical / in-vitro research on energy metabolism. | View |
| CJC-1295 | Growth hormone | GHRH analogue | Studied in preclinical / in-vitro research on GH secretion. | View |
| Ipamorelin | Growth hormone | Pentapeptide (ghrelin agonist) | Studied in preclinical / in-vitro research on GH secretion. | View |
| GHRP-2 | Growth hormone | GH-releasing hexapeptide | Studied in preclinical / in-vitro research on GH secretion. | View |
| GHRP-6 | Growth hormone | GH-releasing hexapeptide | Studied in preclinical / in-vitro research on GH secretion. | View |
| Sermorelin | Growth hormone | GHRH analogue (1-29) | Studied in preclinical / in-vitro research on GH secretion. | View |
| Tesamorelin | Growth hormone | GHRH analogue | Studied in preclinical / in-vitro research on metabolism and GH. | View |
| Hexarelin | Growth hormone | Hexapeptide (ghrelin agonist) | Studied in preclinical / in-vitro research on GH secretion. | View |
| IGF-1 LR3 | Growth hormone | Long-acting IGF-1 analogue | Studied in preclinical / in-vitro research on anabolic signalling (in vitro). | View |
| MK-677 (Ibutamoren) | Growth hormone | GH secretagogue (GHS-R agonist) | Studied in preclinical / in-vitro research on GH secretion. | View |
| Semax | Cognition & focus | Synthetic heptapeptide (ACTH-derived) | Studied in preclinical / in-vitro research on neuroprotection. | View |
| Selank | Cognition & focus | Synthetic heptapeptide (tuftsin-derived) | Studied in preclinical / in-vitro research on anxiolytic effects. | View |
| Cerebrolysin | Cognition & focus | Neurotrophic peptide mixture | Studied in preclinical / in-vitro research on neuroprotection. | View |
| Dihexa | Cognition & focus | Hexapeptide (angiotensin IV-derived) | Studied in preclinical / in-vitro research on synaptogenesis. | View |
| P-21 (P021) | Cognition & focus | CNTF-derived peptide | Studied in preclinical / in-vitro research on neurogenesis. | View |
| Epithalon | Longevity & anti-ageing | Tetrapeptide (Ala-Glu-Asp-Gly) | Studied in preclinical / in-vitro research on telomeres and ageing. | View |
| FOXO4-DRI | Longevity & anti-ageing | FOXO4-p53 interaction inhibitor peptide | Studied in preclinical / in-vitro research on cellular senescence. | View |
| Humanin | Longevity & anti-ageing | Mitochondrial-derived peptide | Studied in preclinical / in-vitro research on cytoprotection. | View |
| Thymalin | Immunity | Thymic peptide | Studied in preclinical / in-vitro research on immune modulation. | View |
| Thymosin Alpha-1 | Immunity | Thymic peptide (28 aa) | Studied in preclinical / in-vitro research on immune modulation. | View |
| LL-37 | Immunity | Antimicrobial peptide (cathelicidin) | Studied in preclinical / in-vitro research on innate immunity. | View |
| KPV | Immunity | Tripeptide (Lys-Pro-Val) | Studied in preclinical / in-vitro research on inflammation (in vitro). | View |
| ARA-290 (Cibinetide) | Tissue repair | EPO-derived peptide (11 aa) | Studied in preclinical / in-vitro research on anti-inflammation and neuroprotection. | View |
| PT-141 (Bremelanotide) | Hormonal balance | Cyclic melanocortin peptide | Studied in preclinical / in-vitro research on melanocortin receptors. | View |
| Kisspeptin-10 | Hormonal balance | Regulatory decapeptide | Studied in preclinical / in-vitro research on the reproductive axis. | View |
| Oxytocin | Hormonal balance | Nonapeptide (neurohormone) | Studied in preclinical / in-vitro research on social behaviour. | View |
| Melanotan II | Skin & hair | α-MSH analogue heptapeptide | Studied in preclinical / in-vitro research on melanocortin receptors. | View |
| SNAP-8 | Skin & hair | Octapeptide (acetyl octapeptide-3) | Studied in preclinical / in-vitro research on the appearance of wrinkles (in vitro). | View |
| PAL-GHK | Skin & hair | Palmitoylated tripeptide | Studied in preclinical / in-vitro research on collagen (in vitro). | View |
39 / 39 peptides · links to PubMed literature.
Research peptides — Research Use Only
- Not for human consumption
- Not for the diagnosis, treatment or prevention of any disease